Pfizer’s coronavirus vaccine is expected to get approval in the UK by the end of this week, the Telegraph reports on Monday, citing unidentified government sources.
Key details (via Bloomberg)
“The UK s National Health Service has made plans to start administering vaccines from Dec. 1. Every adult in the country could be vaccinated by April, according to draft plans.”
“The roll-out for people between 18 and 50 years old could start late January, after older people and front line workers are vaccinated, according to the Telegraph.”
Separately, the coronavirus vaccinations in the US will “hopefully” start in less than three weeks, Moncef Slaoui, Head of the government’s Operation Warp Speed, said on CNN’s “State of the Union” on Sunday.
This comes after the US Food and Drug Administration (FDA) approved Regeneron Inc’s antibody ‘cocktail’ for emergency-use authorization. The drug is given as a one-time treatment through an IV.
Meanwhile, Spain and Germany are the first European Union (EU) countries to have a complete vaccination plan in place said the Spanish Prime Minister (PM) Pedro Sanchez speaking at a news conference following the G20 summit, adding that a comprehensive vaccination campaign will start in January.
Commenting on vaccine after the G20 Summit on Sunday, Germany’s Chancellor Angela Merkel has urged COVAX, an initiative set up to provide vaccines to poorer countries, to start talks immediately with producers, per Reuters.
Market reaction
The risk sentiment remains balanced at the weekly opening, as markets digest a raft of latest developments around the COVID-19 vaccine amid mixed virus news globally.
The US dollar index holds Friday’s bounce while trading just below 92.50, as of writing.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
USD/JPY holds near 155.50 after Tokyo CPI inflation eases more than expected
USD/JPY is trading tightly just below the 156.00 handle, hugging multi-year highs as the Yen continues to deflate. The pair is trading into 30-plus year highs, and bullish momentum is targeting all-time record bids beyond 160.00, a price level the pair hasn’t reached since 1990.
AUD/USD stands firm above 0.6500 with markets bracing for Aussie PPI, US inflation
The Aussie Dollar begins Friday’s Asian session on the right foot against the Greenback after posting gains of 0.33% on Thursday. The AUD/USD advance was sponsored by a United States report showing the economy is growing below estimates while inflation picked up.
Gold soars as US economic woes and inflation fears grip investors
Gold prices advanced modestly during Thursday’s North American session, gaining more than 0.5% following the release of crucial economic data from the United States. GDP figures for the first quarter of 2024 missed estimates, increasing speculation that the US Fed could lower borrowing costs.
Ethereum could remain inside key range as Consensys sues SEC over ETH security status
Ethereum appears to have returned to its consolidating move on Thursday, canceling rally expectations. This comes after Consensys filed a lawsuit against the US SEC and insider sources informing Reuters of the unlikelihood of a spot ETH ETF approval in May.
Bank of Japan expected to keep interest rates on hold after landmark hike
The Bank of Japan is set to leave its short-term rate target unchanged in the range between 0% and 0.1% on Friday, following the conclusion of its two-day monetary policy review meeting for April. The BoJ will announce its decision on Friday at around 3:00 GMT.